Optic neuropathy associated with the use of over-the-counter sexual enhancement supplements

Sapir Z Karli, Sophie D Liao, Andrew R Carey, Byron L Lam, Sara T Wester Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA Abstract: This case report details an association of the use of over-the-counter sexual enhancement supplements with atypica...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Karli SZ, Liao SD, Carey AR, Lam BL, Wester ST
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://doaj.org/article/6b970a0e6a2143f9ba9351d6015fc080
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6b970a0e6a2143f9ba9351d6015fc080
record_format dspace
spelling oai:doaj.org-article:6b970a0e6a2143f9ba9351d6015fc0802021-12-02T03:56:15ZOptic neuropathy associated with the use of over-the-counter sexual enhancement supplements1177-5483https://doaj.org/article/6b970a0e6a2143f9ba9351d6015fc0802014-10-01T00:00:00Zhttp://www.dovepress.com/optic-neuropathy-associated-with-the-use-of-over-the-counter-sexual-en-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483 Sapir Z Karli, Sophie D Liao, Andrew R Carey, Byron L Lam, Sara T Wester Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA Abstract: This case report details an association of the use of over-the-counter sexual enhancement supplements with atypical optic neuropathy. A 42-year-old man presented with right-sided headache and vision loss of the right eye, which deteriorated to a single quadrant of hand motion over 11 days. Serial orbital magnetic resonance imaging scans demonstrated progressive orbital optic nerve enhancement extending into the optic canal despite high-dose steroid treatment. The patient eventually admitted to using several over-the-counter sexual enhancement supplements prior to the onset of symptoms and throughout the course of his steroid treatment, which he subsequently discontinued. His vision improved to 20/200 with an expanded visual field. Anterior ischemic optic neuropathy has been reported in association with phosphodiesterase (PDE)-5 inhibitor use, but visual loss in association with unregulated sexual enhancement supplements has not been studied. While one case cannot establish association, our case is suggestive of potential dangers of over-the-counter sexual enhancement supplements, which may contain PDE-5 inhibitors, “male hormones,” and “substances that enhance blood production.” The case also underscores the importance of obtaining a careful history of supplements in patients with optic neuropathies. Keywords: optic neuropathy, PDE-5 inhibitor, sildenafilKarli SZLiao SDCarey ARLam BLWester STDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2014, Iss default, Pp 2171-2175 (2014)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Karli SZ
Liao SD
Carey AR
Lam BL
Wester ST
Optic neuropathy associated with the use of over-the-counter sexual enhancement supplements
description Sapir Z Karli, Sophie D Liao, Andrew R Carey, Byron L Lam, Sara T Wester Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA Abstract: This case report details an association of the use of over-the-counter sexual enhancement supplements with atypical optic neuropathy. A 42-year-old man presented with right-sided headache and vision loss of the right eye, which deteriorated to a single quadrant of hand motion over 11 days. Serial orbital magnetic resonance imaging scans demonstrated progressive orbital optic nerve enhancement extending into the optic canal despite high-dose steroid treatment. The patient eventually admitted to using several over-the-counter sexual enhancement supplements prior to the onset of symptoms and throughout the course of his steroid treatment, which he subsequently discontinued. His vision improved to 20/200 with an expanded visual field. Anterior ischemic optic neuropathy has been reported in association with phosphodiesterase (PDE)-5 inhibitor use, but visual loss in association with unregulated sexual enhancement supplements has not been studied. While one case cannot establish association, our case is suggestive of potential dangers of over-the-counter sexual enhancement supplements, which may contain PDE-5 inhibitors, “male hormones,” and “substances that enhance blood production.” The case also underscores the importance of obtaining a careful history of supplements in patients with optic neuropathies. Keywords: optic neuropathy, PDE-5 inhibitor, sildenafil
format article
author Karli SZ
Liao SD
Carey AR
Lam BL
Wester ST
author_facet Karli SZ
Liao SD
Carey AR
Lam BL
Wester ST
author_sort Karli SZ
title Optic neuropathy associated with the use of over-the-counter sexual enhancement supplements
title_short Optic neuropathy associated with the use of over-the-counter sexual enhancement supplements
title_full Optic neuropathy associated with the use of over-the-counter sexual enhancement supplements
title_fullStr Optic neuropathy associated with the use of over-the-counter sexual enhancement supplements
title_full_unstemmed Optic neuropathy associated with the use of over-the-counter sexual enhancement supplements
title_sort optic neuropathy associated with the use of over-the-counter sexual enhancement supplements
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/6b970a0e6a2143f9ba9351d6015fc080
work_keys_str_mv AT karlisz opticneuropathyassociatedwiththeuseofoverthecountersexualenhancementsupplements
AT liaosd opticneuropathyassociatedwiththeuseofoverthecountersexualenhancementsupplements
AT careyar opticneuropathyassociatedwiththeuseofoverthecountersexualenhancementsupplements
AT lambl opticneuropathyassociatedwiththeuseofoverthecountersexualenhancementsupplements
AT westerst opticneuropathyassociatedwiththeuseofoverthecountersexualenhancementsupplements
_version_ 1718401554563727360